ZBTB16 Gene Leukemia Acute Promyelocytic PL2FRARA Type Genetic Test sale cost 4400 AED
PTEN Gene Cowden Syndrome Type 1 Genetic Test sale cost 4400 AED PTEN Gene Cowden Syndrome Type 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
EZH2 Gene Leukemia Lymphoblastic and Myeloid EZH2 Related Genetic Test sale cost 4400 AED EZH2 Gene Leukemia Lymphoblastic and Myeloid EZH2 Related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

ZBTB16 Gene Leukemia Acute Promyelocytic PL2FRARA Type Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ZBTB16 Gene Leukemia Acute Promyelocytic PLZF/RARA Type Genetic Test is a sophisticated diagnostic procedure aimed at identifying the specific genetic mutation associated with a subtype of acute promyelocytic leukemia (APL). This particular type of leukemia, characterized by the fusion of the ZBTB16 (also known as PLZF) gene and the RARA gene, results in a unique clinical presentation and requires targeted treatment strategies. The test is crucial for the accurate diagnosis and management of patients, guiding therapeutic decisions that are tailored to the genetic profile of the leukemia.

Performed at DNA Labs UAE, a leading facility in genetic testing, this test utilizes advanced molecular techniques to detect the presence of the ZBTB16-RARA fusion gene. The cost of the test is 4400 AED, reflecting the comprehensive analysis and the specialized technology employed to achieve precise results. Identifying the genetic underpinnings of acute promyelocytic leukemia through this test is pivotal for implementing effective treatment plans, including the potential use of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO), which have shown significant success in patients with specific genetic mutations.

Given the complexity and the life-threatening nature of leukemia, the ZBTB16 Gene Leukemia Acute Promyelocytic PLZF/RARA Type Genetic Test represents a crucial step forward in personalized medicine, offering hope for improved outcomes through targeted therapy.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ZBTB16 Gene Leukemia Acute Promyelocytic PL2FRARA Type Genetic Test

Welcome to DNA Labs UAE, your trusted genetic lab in UAE. Today, we will be discussing the ZBTB16 Gene Leukemia Acute Promyelocytic PL2FRARA Type Genetic Test, its cost, symptoms, diagnosis, and other important details.

Test Name: ZBTB16 Gene Leukemia Acute Promyelocytic PL2FRARA Type Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Genetics

Pre Test Information:

Before undergoing the ZBTB16 Gene Leukemia Acute Promyelocytic PL2FRARA Type Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with ZBTB16 Gene Leukemia Acute Promyelocytic PL2FRARA Type NGS Genetic DNA Test gene ZBTB16.

Test Details:

The ZBTB16 gene, also known as PLZF (promyelocytic leukemia zinc finger), plays a crucial role in the development and function of various cell types, including immune cells and stem cells. Mutations or alterations in the ZBTB16 gene have been associated with different types of leukemia, including acute promyelocytic leukemia (APL).

APL is a subtype of acute myeloid leukemia (AML) characterized by the fusion of the promyelocytic leukemia (PML) gene with the retinoic acid receptor alpha (RARA) gene. This fusion gene, known as PML-RARA, disrupts normal cellular processes and leads to the development of leukemia.

Next-Generation Sequencing (NGS) genetic testing is a cutting-edge technique that allows for the simultaneous analysis of multiple genes. It helps identify mutations or alterations that may be associated with a particular disease or condition. In the case of APL, NGS genetic testing can detect the presence of the PML-RARA fusion gene, as well as other genetic abnormalities relevant for diagnosis, prognosis, or treatment decisions.

Therefore, the ZBTB16 gene test, specifically targeting the PL2F/RARA type, involves the analysis of the ZBTB16 gene and the detection of the PL2F/RARA fusion gene using NGS technology. This test provides valuable information for the diagnosis and management of APL patients.

If you are concerned about ZBTB16 Gene Leukemia Acute Promyelocytic PL2FRARA Type, we are here to help. Our experienced oncologists and genetic testing experts at DNA Labs UAE are dedicated to providing accurate and timely results to assist in your diagnosis and treatment decisions.

Contact us today to schedule your ZBTB16 Gene Leukemia Acute Promyelocytic PL2FRARA Type Genetic Test. Your health is our priority!

Test Name ZBTB16 Gene Leukemia acute promyelocytic PL2FRARA type Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ZBTB16 Gene Leukemia, acute promyelocytic, PL2F/RARA type NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ZBTB16 Gene Leukemia, acute promyelocytic, PL2F/RARA type NGS Genetic DNA Test gene ZBTB16
Test Details

The ZBTB16 gene, also known as PLZF (promyelocytic leukemia zinc finger), is involved in the development and function of various cell types, including immune cells and stem cells. Mutations or alterations in the ZBTB16 gene have been associated with different types of leukemia, including acute promyelocytic leukemia (APL).

APL is a subtype of acute myeloid leukemia (AML) characterized by the fusion of the promyelocytic leukemia (PML) gene with the retinoic acid receptor alpha (RARA) gene. This fusion gene, known as PML-RARA, disrupts normal cellular processes and leads to the development of leukemia.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify mutations or alterations that may be associated with a particular disease or condition. In the context of APL, NGS genetic testing can be used to detect the presence of the PML-RARA fusion gene, as well as other genetic abnormalities that may be relevant for diagnosis, prognosis, or treatment decisions.

Therefore, a ZBTB16 gene test, specifically targeting the PL2F/RARA type, would involve the analysis of the ZBTB16 gene and the detection of the PL2F/RARA fusion gene using NGS technology. This test can provide valuable information for the diagnosis and management of APL patients.

SKU: TEST-4510 Category:

Related products